# Study of XL820 in Adults With Solid Tumors

> **NCT00129571** · PHASE1 · COMPLETED · sponsor: **Exelixis**

## Conditions studied

- Cancer

## Interventions

- **DRUG:** XL820

## Key facts

- **NCT ID:** NCT00129571
- **Lead sponsor:** Exelixis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2008-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00129571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00129571, "Study of XL820 in Adults With Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00129571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*